Navigation Links
Patient Safety Technologies Reports Second Quarter 2011 Results
Date:8/16/2011

IRVINE, Calif., Aug. 16, 2011 /PRNewswire/ -- Patient Safety Technologies, Inc. (the "Company", OTCBB: PSTX, OTCQB: PSTX) today announced financial results for its second quarter of 2011 ended June 30, 2011.

Financial HighlightsDuring the second quarter of 2011, the number of institutions using the Company's SurgiCount Safety-Sponge® System surpassed 70 and the Company lost no customers.  This compares to approximately 52 institutions using the solution at the end of the second quarter of 2010.  Although not necessarily proportional to reported revenue, the number of hospitals using the Company's products is a good indicator of our underlying business.

Total revenue for the quarter ended June 30, 2011 was $2.6 million, which included $0.5 million of revenue from the delivery to the Company's exclusive distributor as part of a $10.0 million inventory stocking order.  Excluding the effect of this inventory stocking order, revenue for the quarter ended June 30, 2011 was $2.1 million.  This compares with total revenue for the quarter ended June 30, 2010 of $3.8 million, which included $2.3 million of revenue from the delivery under the same $10 million inventory stocking order.  Excluding the effect of this inventory stocking order, revenue for the second quarter of 2010 would have been $1.4 million.  Accordingly, excluding the effects of this inventory stocking order, revenue for the three months ended June 30, 2011 of $2.1 million represents approximately 50% growth over the $1.4 million generated for the three months ended June 30, 2010.
This growth in revenue excluding the effects of the stocking order is primarily the result of the significant growth in the number of hospitals using the Safety-Sponge® System at the end of the second quarter of 2011 as compared to the second quarter of 2010.  Additionally, during the second quarter 2011, the Company successfully completed the delivery of the last of
'/>"/>

SOURCE Patient Safety Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 The Medical ... featured in the American Medical Group Association,s "High ... AMGA,s "High Performing Health" production is ... facing the nation,s healthcare system in delivering better ... profiled along with other leading organizations in the ...
(Date:3/31/2015)... -- RnRMarketResearch.com adds "Pemphigus - Pipeline ... 68 pages with latest updates, data and information ... The report "Pemphigus - Pipeline Review, H1 2015" report provides ... Pemphigus , complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:3/31/2015)... 31, 2015  Mark Farrah Associates (MFA), ... (MA) plans in their recent analysis brief.  According ... enrolled in Medicare Advantage plans as of March ... members year-over-year.  54.3 million people are eligible for ... Medicaid Services (CMS), with an unpenetrated market of ...
Breaking Medicine Technology:AMGA's High Performing Health News Program Features The Medical Letter 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2
... NEW YORK, Oct. 13, 2011 Techstreet, ... providing corporate subscriptions to the International Society for Pharmaceutical ... publications it currently offers. The online subscription service is ... it provides unlimited access to the latest ISPE Documents ...
... 2011 K-V Pharmaceutical Company (the "Company") (NYSE: ... and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine ... healthcare providers, patients, and the payer community have ... emphasizes that previous ACOG and SMFM statements regarding ...
Cached Medicine Technology:Techstreet and the ISPE Extend Partnership to Expedite Drug Research with Subscription Offering for Life Science Engineers 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8
(Date:3/31/2015)... 2015 As the scientific community gathers ... Network (GEBN) is poised to make meaningful contributions ... GEBN is a network of scientists from North ... and Oceania who have banded together to further the ... body (energy balance) and apply this understanding to develop ...
(Date:3/31/2015)... March 31, 2015 Tickets are now ... and Denver tradition since 1973. The 2015 Spring production, ... Showtime on Ice. On April 24 in partnership with ... and opening night tribute to the Pat Bowlen family, ... portion of the opening event proceeds will go to ...
(Date:3/31/2015)... QMedET Solutions, LLC, is now offering ... most advanced speech recognition technology to another important ... experience the full benefits of a speech-enabled practice ... services that ensure successful integration with leading Electronic ... to provide Dragon Medical Practice Edition 2 as ...
(Date:3/31/2015)... AL (PRWEB) March 31, 2015 The ... will be discussed during a Case Management Conference ... Southern District of New York on April 21st. According ... of a multidistrict litigation established for Mirena lawsuits filed ... ectopic pregnancies and other serious complications related to the ...
(Date:3/31/2015)... These two automakers will address an audience of ... highlight a shift that has become apparent in the ... proposition for the insurance carriers alone. With connected car ... lie in store for them. , Beyond ... alive to their own involvement in the insurance process ...
Breaking Medicine News(10 mins):Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 3Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3Health News:TU-Automotive: Fiat and Renault-Nissan at the Centre of a Motor Insurance Evolution 2
... Action Network and the American Association for Cancer Research ... the Whitehead Institute for Biomedical Research, and Oliver G. ... the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership ... in research funding, will be formally awarded at the ...
... the gym, surrounded by others, pounding to the beat in group ... it comes to the experience of changing in the locker room, ... of others, can be very discomfiting. It,s a complex experience as ... in any other space. "I walk into the change room ...
... Mich. Less than 2 percent of low-income mothers met ... compared with a more affluent population and a lack ... role. The research findings out of Michigan State University ... among women of lower socioeconomic status, physicians can play a ...
... associated with lower risk of heart disease, but data ... A total of 83,578 female participants of the Nurses, ... and cancer at baseline were followed-up from 1980 to ... baseline and updated approximately every 4 years, whereas stroke ...
... March 15 (HealthDay News) -- People who have mild vascular ... have vascular disease in the brain that causes thinking and ... women with an average age of 69 whose thinking and ... women,s eyes were tested about four years into the study, ...
... that there is a clear relationship between androgenetic alopecia ... benign enlargement of the prostate that appears in aging ... This condition appears in 50% of men over 60 ... In the light of the study published in ...
Cached Medicine News:Health News:Pancreatic Cancer Action Network-AACR Pathway to Leadership grants 2Health News:Pancreatic Cancer Action Network-AACR Pathway to Leadership grants 3Health News:Pancreatic Cancer Action Network-AACR Pathway to Leadership grants 4Health News:The stress of undress 2Health News:The stress of undress 3Health News:Very few low-income moms meet breastfeeding recommendations 2Health News:Moderate drinking associated with lower risk of stroke in women 2Health News:Eyes a Window Into Brain Health: Study 2Health News:A study confirms the correlation between premature alopecia and prostate conditions 2
... is a 5.5 mm diameter bioabsorbable suture ... the cortical bone surface to maximize fixation ... design substantially improves pull-out strength compared to ... threaded design prevents anchor pull-back that may ...
... mm x 14 mm bioabsorbable threaded suture anchor ... elbow and ankle. The exclusive braided suture eyelet ... anchor and provides superior resistance to suture abrasion ... design allows the attached suture to slide smoothly ...
... FiberWire Suture Kit is available ... approximation procedures. This kit contains ... including three different colored versions ... suture differentiation, large cutting Spring ...
TigerStick is a white #2 FiberStick with black stripes and a stiffened, 12 inch, waxed end. It is especially useful when motion determination and alternating colored sutures are required in the arthr...
Medicine Products: